Join Us at Injectable Innovations Conclave
#InjectableInnovationsConclave
11th July 2025
10:30 AM to 8:30 PM
Followed by Cocktails & dinner
Le Meridien
Hyderabad
About the Event
India Pharma Inc, with its vast talent pool and expertise in generic drug manufacturing, has a clear competitive edge in the production of complex generics, and the companies that can navigate this intricate development process are poised for substantial benefits in the years ahead.
The injectables market is particularly enticing as the expanding geriatric population, rising incidence of chronic disorders, government policies, patent expirations of branded drugs and technological advancements will spur growth in the foreseeable future.
Therefore, Express Pharma is organising a one-day conference, 'Injectable Innovations Summit' on the advancements in injectable formulations and drug delivery on July 2025 at Hyderabad. It will bring together industry experts, researchers and innovators to explore and discuss the latest breakthroughs in injectable drug formulation and delivery systems. The conference will focus on latest advancements, challenges, and opportunities, cutting-edge technologies, and sustainable practices transforming the landscape of injectable formulations. Read more
Gain access to the latest trends, technologies, and business strategies shaping India's generic injectables market
Connect with industry leaders, decision-makers, and professionals
Acquire in-depth knowledge of the market dynamics, competitor landscapes, and regulatory changes
Stay informed about the latest government policies and regulatory frameworks impacting the pharma industry
Explore advancements in drug delivery systems, including self-injection devices and more
Learn about successful market entry and expansion strategies to capitalise on new opportunities within India's generic injectables market
Participate in collaborative discussions to share experiences and learn from industry peers
CXOs in
Injectables development
R&D Formulation
Technology Transfer
Extractables & Leachables
R&D Packaging
Sterilisation
Drug Delivery
Quality
Regulatory Affairs
Dr Bhaskar Chauhan
Leading R&D and Quality Management, Puniska Injectable
Dr Mayur Sankalia
VP - Research & Development, Invengene
Mr Vidwans Rajendra Ramachandra
Senior Consultant GMP, QA, in Sterile, Non-sterile dosage forms, Gap analysis
Mr Kiran Deshmukh
Site Head - Sterile Injectables, Lupin
Mr Loganathan S
AVP, Onesource Pharma
Mr Raja Sekhar Reddy Vanga
VP - Global Regulatory Affairs, Biocon Biologics
Mr Rajesh Kumar Chopra
President - Operations, ICHOR Biologics
Ms Leena Padala
Head - Packaging Development & Opex (R&D), Eugia Pharma Research Centre
Mr Rakesh Kumar Sinha
VP & Head-Drug Product Manufacturing, Biological E
Mr Santosh Katti
VP - Drug Product Operations, Biocon Biologics
Dr Pavan Bhat
CEO, Inventia Healthcare
Dr Sanjay Umachigi
GM - Formulations Development, MSN Laboratories
Dr Amarender Reddy Donthidi
Head (R&D Injectables and Ophthalmics), Amneal Pharmaceuticals
Mr Shaunak J Dave
MD & CEO, Antares Vision India